Giant cell myocarditis following COVID‐19 successfully treated by immunosuppressive therapy

It has been shown that severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), by coronavirus disease 2019 (COVID‐19), can lead to multi‐organ impairment including cardiac involvement and immunological problems. Acute myocarditis is one of serious and fatal complications of COVID‐19. In this c...

Descripción completa

Detalles Bibliográficos
Autores principales: Amiri, Afsaneh, Houshmand, Golnaz, Taghavi, Sepideh, Kamali, Monireh, Faraji, Mona, Naderi, Nasim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361461/
https://www.ncbi.nlm.nih.gov/pubmed/35957785
http://dx.doi.org/10.1002/ccr3.6196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361461/
https://www.ncbi.nlm.nih.gov/pubmed/35957785
http://dx.doi.org/10.1002/ccr3.6196

Ejemplares similares